Lin Tang; Lun Li; Lifang Huang; Jing An; Yang Zhou; Yi Liu; Xiaoxue Liu; Qianqian Liu; Xiaoqi Wang; Siyu Liu; Hong Yang; Ning Wen; Zundong Yin; Fuzhen Wang; Lin Tang; Lun Li; Lifang Huang; Jing An; Yang Zhou; Yi Liu; Xiaoxue Liu; Qianqian Liu; Xiaoqi Wang; Siyu Liu; Hong Yang; Ning Wen; Zundong Yin; Fuzhen Wang

doi:10.46234/ccdcw2025.108

[1]

Kyuregyan KK, Kichatova VS, Isaeva OV, Potemkin IA, Malinnikova EY, Lopatukhina MA, et al. Coverage with timely administered vaccination against hepatitis B virus and its influence on the prevalence of HBV infection in the regions of different endemicity. Vaccines 2021;9(2):82. https://doi.org/10.3390/vaccines9020082.

[2]

World Health Organization. Hepatitis B. 2024. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. [2025-3-20].

[3]

Miao N, Wang FZ, Zheng H, Yin ZD, Zhang GM. Hepatitis B vaccine coverage and factors influencing coverage among children 1-14 years of age in China in 2020. Chin J Vaccines Immun 2022;28(6):679 − 83. https://doi.org/10.19914/j.CJVI.2022125.

[4]

Zheng H, Wang Y, Wang FZ, Shen LP, Zhang GM, Liu JH, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Health West Pac 2024;51:101193. https://doi.org/10.1016/j.lanwpc.2024.101193.

[5]

Lu QB, Cui F. Preventing mother-to-child transmission of HBV. Lancet Infect Dis 2022;22(8):1096 − 7. https://doi.org/10.1016/S1473-3099(22)00216-X.

[6]

World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. Wkly Epidemiol Rec 2017;92(27):369-92. https://www.who.int/publications/i/item/WER9227.

[7]

Wang FZ, Zhang GM, Zheng H, Miao N, Shen LP, Wang F, et al. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China. Vaccine 2017;35(33):4229 − 35. https://doi.org/10.1016/j.vaccine.2017.06.019.

[8]

Zhou Y, Lu ZJ, He HQ, Yan R, Deng X, Tang XW, et al. Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: a 5-year prospective study in Zhejiang Province, China (2016-2020). J Viral Hepat 2021;28(10):1413 − 21. https://doi.org/10.1111/jvh.13581.

[9]

Wang W, Luo YL, Tang WP, Chen JH, Wang LL. Current status of post-vaccination serological test after children born among HBsAg-positive mothers in Baoan District of Shenzhen City. Chin J Health Educ 2021;37(10):880 − 3. https://doi.org/10.16168/j.cnki.issn.1002-9982.2021.10.004.

[10]

Schillie S, Walker T, Veselsky S, Crowley S, Dusek C, Lazaroff J, et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics 2015;135(5):e1141 − 7. https://doi.org/10.1542/peds.2014-3213.

[11]

Lu Y, Song YR, Zhai XJ, Zhu FC, Liu JX, Chang ZJ, et al. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus. Emerg Microbes Infect 2021;10(1):555 − 64. https://doi.org/10.1080/22221751.2021.1899055.

[12]

Boucheron P, Lu Y, Yoshida K, Zhao TS, Funk AL, Lunel-Fabiani F, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis 2021;21(1):85 − 96. https://doi.org/10.1016/S1473-3099(20)30593-4.

[13]

Qin W, Wang Y, Zhang XQ, Pan F, Cheng K, Sui HT, et al. A retrospective study of hepatitis B vaccination in preterm birth and low birth weight infants born to hepatitis B surface antigen-positive mothers: time to close the policy-practice gap. Hum Vaccin Immunother 2022;18(7):2155390. https://doi.org/10.1080/21645515.2022.2155390.

[14]

Deng K, Liang J, Mu Y, Liu Z, Wang YP, Li MR, et al. Preterm births in China between 2012 and 2018: an observational study of more than 9 million women. Lancet Glob Health 2021;9(9):e1226 − 41. https://doi.org/10.1016/S2214-109X(21)00298-9.

[15]

Soans S, Mihalyi A, Berlaimont V, Kolhapure S, Dash R, Agrawal A. Vaccination in preterm and low birth weight infants in India. Hum Vaccin Immunother 2022;18(1):1 − 12. https://doi.org/10.1080/21645515.2020.1866950.

[16]

Hofstetter AM, Jacobson EN, deHart MP, Englund JA. Early childhood vaccination status of preterm infants. Pediatrics 2019;144(3):e20183520. https://doi.org/10.1542/peds.2018-3520.

[17]

Ijaz S, Derrick J, Shute J, Ireland G, Hayden I, Ngui SL, et al. Mother to infant transmission of hepatitis B virus in the face of neonatal immunization is not necessarily primary vaccine failure. Clin Infect Dis 2022;74(7):1151 − 7. https://doi.org/10.1093/cid/ciab622.

[18]

Yin XR, Han GR, Zhang H, Wang M, Zhang WJ, Gao YF, et al. A real-world prospective study of mother-to-child transmission of HBV in China using a mobile health application (Shield 01). J Clin Transl Hepatol 2020;8(1):1 − 8. https://doi.org/10.14218/JCTH.2019.00057.